Prescribing of GLP-1 Receptor Agonists for Adolescents with Obesity and Associated Disparities
Kim, C.; Sharifi, M.; Ross, J. S.; Chen, Y.; Xu, H.; Krumholz, H.; Lu, Y.
Show abstract
This retrospective cohort study examined national prescribing patterns of glucagon like peptide 1 receptor agonists (GLP1RAs) for U.S. adolescents with obesity using electronic health record data from over 2 million patients aged 12 to 17 years between 2021 and 2025. Among eligible adolescents, only 0.9 received a GLP1RA prescription, though use increased after semaglutide approval in December 2022, with semaglutide rapidly surpassing liraglutide and off-label tirzepatide use rising by 2025. Prescribing was strongly associated with clinical and sociodemographic factors: adolescents with severe obesity were more likely to be prescribed, while males, Hispanic/Latino and non Hispanic Black youth, non English/Spanish speakers, those living in rural or socioeconomically disadvantaged areas, and those with Medicaid or self pay coverage were significantly less likely to receive prescriptions. These findings highlight growing uptake of GLP1RAs but reveal substantial disparities in access, suggesting insurance barriers and structural inequities may limit availability for groups disproportionately affected by obesity.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clinical Characteristics Of Users Of Weight Loss Drugs: Population-Based Case-Control Study 93%
- Comparative Effects of Weight Loss and Incretin-Based Therapies on Endothelial Vasodilatory and Fibrinolytic Function 91%
- County-level Socio-Environmental Factors and Obesity Prevalence in the United States 91%
Similar papers in this journal
- Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: an observational cohort study using the OpenSAFELY platform 91%
- Robust causal inference for long-term policy decisions: cost effectiveness of interventions for obesity using Mendelian randomization 89%
- Association of puberty timing with Type 2 diabetes: Systematic review and meta-analysis 88%
Similar papers in this journal
- Medication, Vaccine, and Folic Acid Use Among Pregnant Women in Belgium: Insights from the BELpREG Cohort 89%
- Emulating randomized controlled trials of long-acting insulins and cardiovascular events using real-world data for patients with type 2 diabetes 89%
- Pregnancy pharmacoepidemiology: How often are key methodological elements reported in publications? 87%
Similar papers in this journal
- The Impact of the “Muslim Ban” Executive Order on Healthcare Utilization in Minneapolis-St. Paul, Minnesota 90%
- The influence of genetic predisposition and physical activity on risk of Gestational Diabetes Mellitus in the nuMoM2b cohort 89%
- Changes in cardiorespiratory fitness and body mass index due to COVID-19 mitigation measures in Austrian children aged 7 to 10 years 89%
Similar papers in this journal
- Efficacy and safety of phentermine/topiramate in adults with overweight or obesity: A meta-analysis and systematic review 92%
- National, state, and county estimates of adult overweight and obesity from electronic health records and kiosks in retail locations, 2024-2025 91%
- The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, Baseline Data, and Early Insights. 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.